ATE522228T1 - Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung - Google Patents

Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung

Info

Publication number: ATE522228T1
Authority: AT; Austria
Prior art keywords: vaccine formulation; excipient; subcutaneous administration; containing vaccine; allergen
Prior art date: 2007-03-28

Application number

AT07105094T

Other languages

English (en)

Inventor

Eike Gunther Wuestenberg

Original Assignee

Alk Abello As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-28

Filing date

2007-03-28

Publication date

2011-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38093538&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE522228(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-03-28 Application filed by Alk Abello As filed Critical Alk Abello As

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE522228T1 publication Critical patent/ATE522228T1/de

Links

239000000203 mixture Substances 0.000 title abstract 6
238000009472 formulation Methods 0.000 title abstract 3
229960005486 vaccine Drugs 0.000 title abstract 3
238000007920 subcutaneous administration Methods 0.000 title 1
239000013566 allergen Substances 0.000 abstract 4
206010020751 Hypersensitivity Diseases 0.000 abstract 1
208000026935 allergic disease Diseases 0.000 abstract 1
230000007815 allergy Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
230000001932 seasonal effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

AT07105094T 2007-03-28 2007-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung ATE522228T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP07105094A EP1974745B1 (de)	2007-03-28	2007-03-28	Verwendung einer hilfsstoffhaltigen Impfstoffformulierung für subkutane Verabreichung

Publications (1)

Publication Number	Publication Date
ATE522228T1 true ATE522228T1 (de)	2011-09-15

Family

ID=38093538

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT07105094T ATE522228T1 (de)	2007-03-28	2007-03-28	Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung
AT08153545T ATE540691T1 (de)	2007-03-28	2008-03-28	Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT08153545T ATE540691T1 (de)	2007-03-28	2008-03-28	Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung

Country Status (5)

Country	Link
US (1)	US20120141536A1 (de)
EP (1)	EP1974745B1 (de)
AT (2)	ATE522228T1 (de)
DK (2)	DK1974745T3 (de)
ES (2)	ES2370043T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2645740T3 (es)	2012-10-19	2017-12-07	Hal Allergy Holding B.V.	Composiciones para inmunoterapia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4031199A (en)	1972-12-11	1977-06-21	Merck Patent Gesellschaft Mit Beschrankter Haftung	Process for the production of allergen-containing extracts
CA2554337A1 (en)	2004-02-06	2005-08-25	Greer Laboratories, Inc.	Methods and compositions for dosing of allergens
JP2007524096A (ja)	2004-02-26	2007-08-23	アルカベロアクチェセルスカプ	粘膜投与用ワクチンの治療可能性の評価方法
US20060115499A1 (en) *	2004-09-27	2006-06-01	Alk-Abello A/S	Liquid allergy vaccine formulation for oromucosal administration

2007
- 2007-03-28 ES ES07105094T patent/ES2370043T3/es active Active
- 2007-03-28 AT AT07105094T patent/ATE522228T1/de not_active IP Right Cessation
- 2007-03-28 DK DK07105094.2T patent/DK1974745T3/da active
- 2007-03-28 EP EP07105094A patent/EP1974745B1/de active Active
2008
- 2008-03-28 US US12/593,263 patent/US20120141536A1/en not_active Abandoned
- 2008-03-28 AT AT08153545T patent/ATE540691T1/de active
- 2008-03-28 DK DK08153545.2T patent/DK1974746T3/da active
- 2008-03-28 ES ES08153545T patent/ES2380172T3/es active Active

Also Published As

Publication number	Publication date
ES2380172T3 (es)	2012-05-09
US20120141536A1 (en)	2012-06-07
ES2370043T3 (es)	2011-12-12
EP1974745B1 (de)	2011-08-31
EP1974745A1 (de)	2008-10-01
ATE540691T1 (de)	2012-01-15
DK1974746T3 (da)	2012-04-10
DK1974745T3 (da)	2011-11-28

Similar Documents

Publication	Publication Date	Title
CO6670520A2 (es)	2013-05-15	Lactmas sustituidas con piperidinio como moduladores de gpr119
BR112013029256A8 (pt)	2018-01-16	combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
MX366314B (es)	2019-07-05	Uso de derivados de insulina por inyecciones con intervalos variables.
EA201070757A1 (ru)	2011-02-28	Режим дозирования инъекционных препаратов эфиров палиперидона длительного действия
BR112012027759A2 (pt)	2017-08-15	Conjugados de peptídeos de agonistas de receptores glp-1 e gastrina e seu uso
EA201201657A1 (ru)	2013-06-28	Лечение диабета
UA117570C2 (uk)	2018-08-27	Спосіб лікування діабету або діабету, спричиненого ожирінням, або ускладнень при діабеті
EA201100335A1 (ru)	2011-10-31	Производные пурина для применения при лечении связанных с fab заболеваний
MX366405B (es)	2019-07-08	Uso de peptidos glp-1 de accion prolongada.
SMT201500190B (it)	2015-09-07	Composizioni comprendenti un anticorpo a p2-specifico o un suo frammento per l'uso nel trattamento del diabete, intolleranza al glucosio o insulino-resistenza indotta dall'obesita'
CO6501147A2 (es)	2012-08-15	Inhibidores de mtor cinasa para indicadores de oncología y enfermedades asociadas con la trayectoria mtor/pi3k/akt
HU0800434D0 (en)	2008-08-28	Template to determine the places of the injections, especially for regular medicament injection and/or blood testing
BR112014010590A2 (pt)	2017-05-02	18-metil-6,7-metilen-3-oxo-17-pregn-4-eno-21,17?-carbolactonas, preparações farmacêuticas contendo os compostos mencionados e seu uso na terapia da endometriose
BR112012027197A2 (pt)	2016-07-19	combinação ou composição farmacêutica, seu uso, kit, e compostos para tratamento de doenças oncológicas e fibróticas
NZ719520A (en)	2017-07-28	Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
MX2013011175A (es)	2013-11-01	Analogos de glucagon novedosos.
WO2013028818A8 (en)	2013-09-19	Pyrimido- pyridazinone compounds and use thereof
CY1115862T1 (el)	2017-01-25	Θεραπεια με πιρφενιδονη για ασθενεις με μη φυσιολογικη ηπατικη λειτουργια
UA113849C2 (xx)	2017-03-27	Застосування сигма-лігандів при болю, пов'язаному з діабетом 2 типу
EA201491702A1 (ru)	2015-03-31	Оптимизированные терапевтические агенты для подкожного введения
BR112013010345A2 (pt)	2017-07-25	tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
UY31646A1 (es)	2009-08-31	Uso de fenilimidazolidinas sustituidas para producir medicamentos para el tratamiento del síndrome metabólico
ATE540691T1 (de)	2012-01-15	Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung
CY1111534T1 (el)	2015-08-05	Χρηση αλατων τιοτροπιου στην αντιμετωπιση μετριου επιμονου ασθματος
EP1974746A3 (de)	2008-10-08	Verwendung einer hilfsstoffhaltigen Impfstoffformulierung für parenterale Verabreichung

Legal Events

Date	Code	Title	Description
2012-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties